World Pharma News

Alexandre Joyeux: Erenumab reduces migraine costs in Germany

by Nicole Ntampou By €8.5 billion each year the German economy can potentially reduce losses in GDP, linked to the effects of migraines, he said, at the 13th Annual Conference of the European Association for Headaches, Dr. Alexandre Joyeux – Head, Global…
31 Μαΐου, 2019
World Pharma News